首页 > 最新文献

Acta medica Okayama最新文献

英文 中文
Metastatic Intraocular Tumor Likely from Hepatocellular Carcinoma Mimicking Panuveitis. 转移性眼内肿瘤可能来自肝细胞癌,类似全葡萄膜炎。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70074
Eri Takasu, Yusuke Shiode, Hiroya Kindo, Shuhei Kimura, Mio Hosokawa, Ryo Matoba, Yuki Kanzaki, Tetsuro Morita, Takuya Adachi, Motoyuki Otsuka, Yuki Morizane

A 77-year-old man undergoing treatment for hepatocellular carcinoma (HCC) presented with blurred vision in his right eye, persisting for 2 months. Slit-lamp microscopy and fundus examination revealed inflammatory cells in the anterior chamber, severe vitreous opacities, and retinal vasculitis in the right eye. The patient underwent vitreous surgery with biopsy, and vitreous cytology confirmed a metastatic intraocular tumor originating from the HCC. Radiotherapy was administered to the right eye, with no recurrence of intraocular inflammation observed at 10 months post-irradiation.

一例77岁男性肝癌患者在接受肝细胞癌(HCC)治疗时出现右眼视力模糊,持续2个月。裂隙灯显微镜和眼底检查显示右眼前房炎性细胞,严重玻璃体混浊,视网膜血管炎。患者行玻璃体手术并活检,玻璃体细胞学证实为源自HCC的转移性眼内肿瘤。对右眼进行放疗,放疗后10个月无眼内炎症复发。
{"title":"Metastatic Intraocular Tumor Likely from Hepatocellular Carcinoma Mimicking Panuveitis.","authors":"Eri Takasu, Yusuke Shiode, Hiroya Kindo, Shuhei Kimura, Mio Hosokawa, Ryo Matoba, Yuki Kanzaki, Tetsuro Morita, Takuya Adachi, Motoyuki Otsuka, Yuki Morizane","doi":"10.18926/AMO/70074","DOIUrl":"10.18926/AMO/70074","url":null,"abstract":"<p><p>A 77-year-old man undergoing treatment for hepatocellular carcinoma (HCC) presented with blurred vision in his right eye, persisting for 2 months. Slit-lamp microscopy and fundus examination revealed inflammatory cells in the anterior chamber, severe vitreous opacities, and retinal vasculitis in the right eye. The patient underwent vitreous surgery with biopsy, and vitreous cytology confirmed a metastatic intraocular tumor originating from the HCC. Radiotherapy was administered to the right eye, with no recurrence of intraocular inflammation observed at 10 months post-irradiation.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"63-67"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Stroke Discharge Support Evaluation Scale for Ward Nurses in Acute Care Hospitals. 急性护理医院病区护士脑卒中出院支持评价量表的编制。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70069
Hideki Yano, Yoko Takahata, Takeshi Yamaguchi, Shinya Saito

This study aimed to develop a scale enabling nurses to objectively evaluate their own stroke discharge support, as a basis for enhancing its overall effectiveness. A draft scale was created based on a literature review, and consisted of a 51-item, 5-point Likert-type questionnaire administered to ward nurses engaged in stroke discharge support at acute care hospitals. Factor analysis was performed to refine the scale. Construct validity was assessed using the known-groups method, and reliability was evaluated through internal consistency analysis. The resulting Stroke Discharge Support Evaluation Scale comprises 29 items across 5 factors, each rated on a 5-point Likert scale. Analysis of the data collected from 237 valid responses demonstrated good internal consistency and supported the scale's construct validity. The Stroke Discharge Support Evaluation Scale is a reliable and valid tool enabling ward nurses in acute care hospitals to evaluate their own stroke discharge support.

本研究旨在编制一份量表,使护士能够客观地评估自己的脑卒中出院支持,作为提高其整体有效性的基础。在文献回顾的基础上,编制了一份量表草案,包括51项5分李克特式问卷,对急症护理医院从事中风出院支持的病房护士进行调查。采用因子分析对量表进行细化。结构效度采用已知组法评估,信度采用内部一致性分析评估。由此产生的中风释放支持评估量表包括29个项目,跨越5个因素,每个项目在5分李克特量表上评分。对237份有效问卷的数据分析表明,量表具有良好的内部一致性,支持量表的结构效度。《脑卒中出院支持评估量表》是一种可靠有效的工具,可以帮助急症护理医院的病房护士评估自己的脑卒中出院支持。
{"title":"Development of a Stroke Discharge Support Evaluation Scale for Ward Nurses in Acute Care Hospitals.","authors":"Hideki Yano, Yoko Takahata, Takeshi Yamaguchi, Shinya Saito","doi":"10.18926/AMO/70069","DOIUrl":"10.18926/AMO/70069","url":null,"abstract":"<p><p>This study aimed to develop a scale enabling nurses to objectively evaluate their own stroke discharge support, as a basis for enhancing its overall effectiveness. A draft scale was created based on a literature review, and consisted of a 51-item, 5-point Likert-type questionnaire administered to ward nurses engaged in stroke discharge support at acute care hospitals. Factor analysis was performed to refine the scale. Construct validity was assessed using the known-groups method, and reliability was evaluated through internal consistency analysis. The resulting Stroke Discharge Support Evaluation Scale comprises 29 items across 5 factors, each rated on a 5-point Likert scale. Analysis of the data collected from 237 valid responses demonstrated good internal consistency and supported the scale's construct validity. The Stroke Discharge Support Evaluation Scale is a reliable and valid tool enabling ward nurses in acute care hospitals to evaluate their own stroke discharge support.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"17-30"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective Treatment of Advanced Hepatocellular Carcinoma with Extensive Peritoneal Dissemination Using Lenvatinib. Lenvatinib有效治疗晚期肝细胞癌伴广泛腹膜播散。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70075
Shinya Wakatsuki, Shinya Sakamoto, Akiko Ueno, Takaomi Namba, Yorito Yamamoto, Manabu Matsumoto, Jun Iwata, Takehiro Okabayashi

Patients with hepatocellular carcinoma (HCC) and extensive peritoneal dissemination generally have a poor prognosis and are often resistant to systemic therapy. We report the case of a 47-year-old woman with HCC and massive peritoneal dissemination who presented with malignant ascites requiring repeated cell-free and concentrated ascites reinfusion therapy and peritoneovenous shunt placement, as well as malignant pleural effusion requiring pleurodesis. Combined immunotherapy with durvalumab/tremelimumab was initiated;however, disease progression was observed after three treatment courses, prompting a switch to lenvatinib therapy. Two months after initiation of lenvatinib, CT imaging demonstrated complete disappearance of arterial enhancement in the primary hepatic lesion, along with reduction in the size of peritoneal dissemination nodules. Thirteen months after switching to lenvatinib (16 months after the initial diagnosis), the alpha-fetoprotein level continued to decrease, and the disease remained stable under treatment. Despite the extremely high tumor burden, lenvatinib achieved disease stabilization and symptomatic improvement.

肝细胞癌(HCC)和广泛腹膜播散的患者通常预后较差,并且通常对全身治疗有抵抗力。我们报告一例47岁的HCC伴大量腹膜播散的女性,其表现为恶性腹水,需要反复无细胞和浓缩腹水再输注治疗和腹膜静脉分流术,以及恶性胸腔积液,需要胸膜切除术。启动durvalumab/tremelimumab联合免疫治疗;然而,在三个疗程后观察到疾病进展,促使改用lenvatinib治疗。lenvatinib开始两个月后,CT成像显示原发性肝病变动脉强化完全消失,同时腹膜播散性结节缩小。改用lenvatinib治疗13个月后(初始诊断16个月后),甲胎蛋白水平继续下降,在治疗期间病情保持稳定。尽管肿瘤负担极高,lenvatinib实现了疾病稳定和症状改善。
{"title":"Effective Treatment of Advanced Hepatocellular Carcinoma with Extensive Peritoneal Dissemination Using Lenvatinib.","authors":"Shinya Wakatsuki, Shinya Sakamoto, Akiko Ueno, Takaomi Namba, Yorito Yamamoto, Manabu Matsumoto, Jun Iwata, Takehiro Okabayashi","doi":"10.18926/AMO/70075","DOIUrl":"10.18926/AMO/70075","url":null,"abstract":"<p><p>Patients with hepatocellular carcinoma (HCC) and extensive peritoneal dissemination generally have a poor prognosis and are often resistant to systemic therapy. We report the case of a 47-year-old woman with HCC and massive peritoneal dissemination who presented with malignant ascites requiring repeated cell-free and concentrated ascites reinfusion therapy and peritoneovenous shunt placement, as well as malignant pleural effusion requiring pleurodesis. Combined immunotherapy with durvalumab/tremelimumab was initiated;however, disease progression was observed after three treatment courses, prompting a switch to lenvatinib therapy. Two months after initiation of lenvatinib, CT imaging demonstrated complete disappearance of arterial enhancement in the primary hepatic lesion, along with reduction in the size of peritoneal dissemination nodules. Thirteen months after switching to lenvatinib (16 months after the initial diagnosis), the alpha-fetoprotein level continued to decrease, and the disease remained stable under treatment. Despite the extremely high tumor burden, lenvatinib achieved disease stabilization and symptomatic improvement.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"69-74"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time Course of the Development and Loss of Delta-9-tetrahydrocannabinol Tolerance: Effects on Hypothermia and Spontaneous Locomotor Activity in Mice. δ -9-四氢大麻酚耐受性产生和丧失的时间过程:对小鼠低温和自发运动活动的影响。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70072
Yukiomi Eguchi, Soichiro Ushio, Keiichi Irie, Yuta Yamashita, Miyu Eguchi, Takafumi Nakano, Kenichi Mishima

Deregulation of cannabis use is gradually expanding in Europe and the United States. However, the biological processes driving tolerance to delta-9-tetrahydrocannabinol (Δ9-THC), the main psychoactive component of cannabis, remain unclear. Thus, this study aimed to investigate the mechanisms and time course of tolerance development and loss to Δ9-THC in mice. Male ICR mice (7 weeks old) were administered Δ9-THC once daily for 3 days and then divided into three groups according to the washout period (3-, 10-, and 17-day washout groups). After each washout, changes in body temperature and locomotor activity were measured following re-exposure to Δ9-THC. Furthermore, the mRNA expression levels of CB1 and CB2 receptors in the brain were evaluated using real-time PCR. On day 1, significant hypothermia and reduced spontaneous locomotor activity were observed in the Δ9-THC-treated mice compared with the vehicle-treated mice. Tolerance to the hypothermic and locomotor-suppressing effects of Δ9-THC developed on days 2 and 3, respectively, and dissipated after 3 and 11 days of washout, respectively. These differences in the rates of tolerance development and recovery may reflect distinct underlying mechanisms. No significant changes in receptor mRNA expression were observed. These findings highlight the complexity of Δ9-THC tolerance and its potential implications for long-term cannabis use.

在欧洲和美国,大麻使用的放松管制正在逐步扩大。然而,对大麻的主要精神活性成分- δ -9-四氢大麻酚(Δ9-THC)产生耐受性的生物学过程仍不清楚。因此,本研究旨在探讨小鼠Δ9-THC耐受性发展和丧失的机制和时间过程。雄性ICR小鼠(7周龄)每天给药Δ9-THC 1次,连续3天,然后根据洗脱期分为3组(3、10、17天洗脱期组)。每次冲洗后,再次暴露于Δ9-THC后测量体温和运动活动的变化。此外,采用实时荧光定量PCR技术检测脑内CB1和CB2受体mRNA表达水平。第1天,与给药小鼠相比,Δ9-THC-treated小鼠的体温明显降低,自发运动活动减少。对Δ9-THC的低温和运动抑制作用的耐受性分别在第2天和第3天形成,分别在第3天和第11天消失。这些耐受性发展和恢复速度的差异可能反映了不同的潜在机制。受体mRNA表达无明显变化。这些发现突出了Δ9-THC耐受性的复杂性及其对长期使用大麻的潜在影响。
{"title":"Time Course of the Development and Loss of Delta-9-tetrahydrocannabinol Tolerance: Effects on Hypothermia and Spontaneous Locomotor Activity in Mice.","authors":"Yukiomi Eguchi, Soichiro Ushio, Keiichi Irie, Yuta Yamashita, Miyu Eguchi, Takafumi Nakano, Kenichi Mishima","doi":"10.18926/AMO/70072","DOIUrl":"10.18926/AMO/70072","url":null,"abstract":"<p><p>Deregulation of cannabis use is gradually expanding in Europe and the United States. However, the biological processes driving tolerance to delta-9-tetrahydrocannabinol (Δ9-THC), the main psychoactive component of cannabis, remain unclear. Thus, this study aimed to investigate the mechanisms and time course of tolerance development and loss to Δ9-THC in mice. Male ICR mice (7 weeks old) were administered Δ9-THC once daily for 3 days and then divided into three groups according to the washout period (3-, 10-, and 17-day washout groups). After each washout, changes in body temperature and locomotor activity were measured following re-exposure to Δ9-THC. Furthermore, the mRNA expression levels of CB1 and CB2 receptors in the brain were evaluated using real-time PCR. On day 1, significant hypothermia and reduced spontaneous locomotor activity were observed in the Δ9-THC-treated mice compared with the vehicle-treated mice. Tolerance to the hypothermic and locomotor-suppressing effects of Δ9-THC developed on days 2 and 3, respectively, and dissipated after 3 and 11 days of washout, respectively. These differences in the rates of tolerance development and recovery may reflect distinct underlying mechanisms. No significant changes in receptor mRNA expression were observed. These findings highlight the complexity of Δ9-THC tolerance and its potential implications for long-term cannabis use.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"47-54"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Prescribing Patterns of Antiviral Drugs before and after Public Coverage Termination among Hospitalized COVID-19 Patients in Regional Hospitals in Japan: A Retrospective, Multicenter Study. 日本地区医院COVID-19住院患者公共覆盖终止前后抗病毒药物处方模式的变化:一项回顾性、多中心研究
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70073
Hidemasa Akazawa, Hideharu Hagiya, Shinnosuke Fukushima, Shohei Yamamoto, Yasuhiro Nakano, Fumio Otsuka

In Japan, antiviral agents for COVID-19 were freely available until September 2023 as part of national policy. This study evaluated changes in these agents' prescribing patterns and the patient outcomes following the policy shift. We conducted a multicenter retrospective study at four hospitals in Japan's Okayama and Kagawa prefectures from January 2022 to March 2024. The study period was divided into the public-expenditure phase (January 2022 to September 2023) and the post-expenditure phase (October 2023 to March 2024). We extracted the hospitalized patients' clinical data from the electronic database. The study's primary outcome was the antiviral prescription rate; the secondary outcome was in-hospital mortality. Among the 302 hospitalized patients (median age 85 years), 52.0% were classified as having a mild condition. Of the patients with mild conditions, 37.7% were diagnosed in outpatient settings prior to hospitalization. During the public-expenditure phase, 47.4% of the patients received antivirals as outpatients, mainly molnupiravir (80.9%). In the post-expenditure period, 80.0% of the patients were prescribed antivirals, mostly molnupiravir (91.7%). The antiviral prescription rate was significantly higher after the policy change. The overall in-hospital mortality was 15.8%, with no significant difference between the two periods (17.0% vs. 10.5%). Despite the termination of government funding, antiviral prescriptions remained frequent at community hospitals located in highly aging regions of western Japan such as Okayama and Kagawa prefectures. Mortality remains high among the elderly, highlighting the need for continued antiviral therapy and booster vaccinations.

在日本,作为国家政策的一部分,直到2023年9月,针对COVID-19的抗病毒药物都是免费提供的。本研究评估了政策转变后这些药物的处方模式和患者预后的变化。我们于2022年1月至2024年3月在日本冈山县和香川县的四家医院进行了一项多中心回顾性研究。研究阶段分为公共支出阶段(2022年1月至2023年9月)和支出后阶段(2023年10月至2024年3月)。我们从电子数据库中提取住院患者的临床资料。该研究的主要结果是抗病毒药物的处方率;次要终点是住院死亡率。在302例住院患者(中位年龄85岁)中,52.0%被归类为轻度疾病。在病情较轻的患者中,37.7%是在住院前在门诊确诊的。在公费阶段,47.4%的患者在门诊接受了抗病毒药物治疗,主要是莫诺匹拉韦(80.9%)。在支出后阶段,80.0%的患者使用抗病毒药物,其中以莫努匹拉韦(91.7%)居多。政策改变后抗病毒药物处方率明显增高。总体住院死亡率为15.8%,两个时期之间无显著差异(17.0%对10.5%)。尽管终止了政府资助,但位于日本西部人口老龄化严重地区的社区医院,如冈山县和香川县,仍然经常开抗病毒处方。老年人的死亡率仍然很高,这突出表明需要继续进行抗病毒治疗和加强疫苗接种。
{"title":"Changes in Prescribing Patterns of Antiviral Drugs before and after Public Coverage Termination among Hospitalized COVID-19 Patients in Regional Hospitals in Japan: A Retrospective, Multicenter Study.","authors":"Hidemasa Akazawa, Hideharu Hagiya, Shinnosuke Fukushima, Shohei Yamamoto, Yasuhiro Nakano, Fumio Otsuka","doi":"10.18926/AMO/70073","DOIUrl":"10.18926/AMO/70073","url":null,"abstract":"<p><p>In Japan, antiviral agents for COVID-19 were freely available until September 2023 as part of national policy. This study evaluated changes in these agents' prescribing patterns and the patient outcomes following the policy shift. We conducted a multicenter retrospective study at four hospitals in Japan's Okayama and Kagawa prefectures from January 2022 to March 2024. The study period was divided into the public-expenditure phase (January 2022 to September 2023) and the post-expenditure phase (October 2023 to March 2024). We extracted the hospitalized patients' clinical data from the electronic database. The study's primary outcome was the antiviral prescription rate; the secondary outcome was in-hospital mortality. Among the 302 hospitalized patients (median age 85 years), 52.0% were classified as having a mild condition. Of the patients with mild conditions, 37.7% were diagnosed in outpatient settings prior to hospitalization. During the public-expenditure phase, 47.4% of the patients received antivirals as outpatients, mainly molnupiravir (80.9%). In the post-expenditure period, 80.0% of the patients were prescribed antivirals, mostly molnupiravir (91.7%). The antiviral prescription rate was significantly higher after the policy change. The overall in-hospital mortality was 15.8%, with no significant difference between the two periods (17.0% vs. 10.5%). Despite the termination of government funding, antiviral prescriptions remained frequent at community hospitals located in highly aging regions of western Japan such as Okayama and Kagawa prefectures. Mortality remains high among the elderly, highlighting the need for continued antiviral therapy and booster vaccinations.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"55-62"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kinesiophobia Is Associated with Disability, Poor Quality of Life, Psychological Morbidity, and Surgery Dissatisfaction in Patients with Lumbar Microdiscetomy: A Cross-Sectional Controlled Study. 一项横断面对照研究:运动恐惧症与腰椎显微切除患者的残疾、生活质量差、心理发病率和手术不满意有关。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70071
Nihal Tezel, Asliı Gençay Can

The study aimed to determine the prevalence of kinesiophobia in patients who had undergone lumbar microdiscectomy and to examine its associations with pain intensity, disability, quality of life, depression, anxiety, and satisfaction with surgery. Forty-eight patients with microdiscectomy and 48 healthy controls were enrolled. The Tampa Scale for Kinesiophobia (TSK), Roland-Morris Disability Index (RMDI), Hospital Anxiety and Depression Scale (HADS-A and HADS-D, respectively), and Short Form-36 Health Survey (SF-36) were administered to both groups. The scores of TSK, RMDI, HADS-A, and HADS-D were significantly higher and SF-36 scores were significantly lower in the microdiscectomy than the control group (p<0.001 for all). In the microdiscectomy group, median (min-max) RMDI, HADS-A, and HADS-D scores were 19 (4-34), 10 (0-18), and 9 (0-18), respectively, in kinesiophobic patients, and were significantly higher than 6 (2-20), 3 (0-11), 2.5 (0-11) in non-kinesiophobic patients (all p<0.001). The median (min-max) SF-36 PCS, SF-36 MCS, and VAS scores for surgery satisfaction were 36.5 (8.7-75), 52.1 (11-95), 5, 5 (0-10), respectively, in kinesiophobic patients and were significantly lower than 71 (28-95), 85.5 (9-93), 8.5 (3-10) in non-kinesiophobic patients (all p<0.05). TSK scores were significantly correlated with RMDI, HADS-A, HADS-D, SF-36, and surgery satisfaction scores (all p<0.05). Kinesiophobic patients with lumbar microdiscectomy therefore showed greater disability and psychological morbidity, poorer quality of life, and lower satisfaction with surgery.

该研究旨在确定腰微椎间盘切除术患者中运动恐惧症的患病率,并研究其与疼痛强度、残疾、生活质量、抑郁、焦虑和手术满意度的关系。48例显微椎间盘切除术患者和48例健康对照者被纳入研究。两组均采用坦帕运动恐惧症量表(TSK)、罗兰-莫里斯残疾指数(RMDI)、医院焦虑和抑郁量表(分别为HADS-A和HADS-D)和SF-36健康调查问卷(SF-36)。微椎间盘切除术组的TSK、RMDI、HADS-A和HADS-D评分显著高于对照组,SF-36评分显著低于对照组(p
{"title":"Kinesiophobia Is Associated with Disability, Poor Quality of Life, Psychological Morbidity, and Surgery Dissatisfaction in Patients with Lumbar Microdiscetomy: A Cross-Sectional Controlled Study.","authors":"Nihal Tezel, Asliı Gençay Can","doi":"10.18926/AMO/70071","DOIUrl":"10.18926/AMO/70071","url":null,"abstract":"<p><p>The study aimed to determine the prevalence of kinesiophobia in patients who had undergone lumbar microdiscectomy and to examine its associations with pain intensity, disability, quality of life, depression, anxiety, and satisfaction with surgery. Forty-eight patients with microdiscectomy and 48 healthy controls were enrolled. The Tampa Scale for Kinesiophobia (TSK), Roland-Morris Disability Index (RMDI), Hospital Anxiety and Depression Scale (HADS-A and HADS-D, respectively), and Short Form-36 Health Survey (SF-36) were administered to both groups. The scores of TSK, RMDI, HADS-A, and HADS-D were significantly higher and SF-36 scores were significantly lower in the microdiscectomy than the control group (p<0.001 for all). In the microdiscectomy group, median (min-max) RMDI, HADS-A, and HADS-D scores were 19 (4-34), 10 (0-18), and 9 (0-18), respectively, in kinesiophobic patients, and were significantly higher than 6 (2-20), 3 (0-11), 2.5 (0-11) in non-kinesiophobic patients (all p<0.001). The median (min-max) SF-36 PCS, SF-36 MCS, and VAS scores for surgery satisfaction were 36.5 (8.7-75), 52.1 (11-95), 5, 5 (0-10), respectively, in kinesiophobic patients and were significantly lower than 71 (28-95), 85.5 (9-93), 8.5 (3-10) in non-kinesiophobic patients (all p<0.05). TSK scores were significantly correlated with RMDI, HADS-A, HADS-D, SF-36, and surgery satisfaction scores (all p<0.05). Kinesiophobic patients with lumbar microdiscectomy therefore showed greater disability and psychological morbidity, poorer quality of life, and lower satisfaction with surgery.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"39-46"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Preoperative Anterior Pelvic Plane Angle Predicts Cup Anteversion Changes at 1 Year after Total Hip Arthroplasty. 术前骨盆前平面角度预测全髋关节置换术后1年的杯前倾改变。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70070
Kyota Ishibashi, Hirotaka Oishi, Ryo Araki, Kosuke Kawamura, Isamu Sasaki, Eiji Sasaki, Hikaru Kamada, Masakazu Kogawa, Sunao Tanaka, Takuya Numasawa, Yasuyuki Ishibashi

We investigated global alignment changes following total hip arthroplasty (THA) and predictive alignment parameters for increased cup anteversion (CA) by retrospectively analyzing the primary THA data of 75 patients treated at our hospital (49 women, 26 men; age 65.1±5.7 years, BMI 28.3±3.4 kg/m2). Global alignment parameters, i.e., the anterior pelvic plane angle (APPa) and proximal femoral shaft angle (PFSa) and other alignment parameters were measured. CA was evaluated based on the patients' standing coronal radiographs. ΔCA was defined as the difference in CA from 2 weeks before to 1 year after each THA. We classified the cases as stable (S) (CA < 10°; n=63) and pelvic retroversion (R) (CA ≥ 10°; n=12) groups. Associations between ΔCA and alignment parameters were evaluated by linear regression and a receiver operating characteristic (ROC) analysis. A significant decrease in the PFSa occurred between the 2-week and 1-year post-THA timepoints (7.8±4.3° vs. 4.2±3.6°, p<0.001), with no notable change in other alignment parameters. At 1-year post-THA, the CA of 12 (16%) patients had increased to 4.5±4.4°. Only the preoperative APPa was positively associated with ΔCA (β=0.165, p=0.020). The ROC analysis revealed that the optimal cut-off value for increased CA in the APPa is 2.1° (area under the curve, 0.700; p=0.020; odds ratio, 4.80). The APPa change predicted increased CA, which emphasizes the importance of the use of preoperative standing radiography for identifying the optimal cup positioning for post-THA changes in CA.

我们通过回顾性分析我院治疗的75例患者(女性49例,男性26例;年龄65.1±5.7岁,BMI 28.3±3.4 kg/m2)的主要THA数据,研究了全髋关节置换术(THA)后的整体对齐变化和杯前倾(CA)增加的预测对齐参数。测量整体对准参数,即骨盆前平面角(APPa)和股骨干近端角(PFSa)等对准参数。根据患者站立冠状位x线片评估CA。ΔCA定义为每次THA术前2周与术后1年CA的差异。我们将病例分为稳定(S)组(CA < 10°,n=63)和骨盆后倾(R)组(CA≥10°,n=12)。通过线性回归和受试者工作特征(ROC)分析评估ΔCA与对齐参数之间的关系。PFSa在tha后2周和1年时间点显著下降(7.8±4.3°vs 4.2±3.6°,p
{"title":"The Preoperative Anterior Pelvic Plane Angle Predicts Cup Anteversion Changes at 1 Year after Total Hip Arthroplasty.","authors":"Kyota Ishibashi, Hirotaka Oishi, Ryo Araki, Kosuke Kawamura, Isamu Sasaki, Eiji Sasaki, Hikaru Kamada, Masakazu Kogawa, Sunao Tanaka, Takuya Numasawa, Yasuyuki Ishibashi","doi":"10.18926/AMO/70070","DOIUrl":"10.18926/AMO/70070","url":null,"abstract":"<p><p>We investigated global alignment changes following total hip arthroplasty (THA) and predictive alignment parameters for increased cup anteversion (CA) by retrospectively analyzing the primary THA data of 75 patients treated at our hospital (49 women, 26 men; age 65.1±5.7 years, BMI 28.3±3.4 kg/m2). Global alignment parameters, i.e., the anterior pelvic plane angle (APPa) and proximal femoral shaft angle (PFSa) and other alignment parameters were measured. CA was evaluated based on the patients' standing coronal radiographs. ΔCA was defined as the difference in CA from 2 weeks before to 1 year after each THA. We classified the cases as stable (S) (CA < 10°; n=63) and pelvic retroversion (R) (CA ≥ 10°; n=12) groups. Associations between ΔCA and alignment parameters were evaluated by linear regression and a receiver operating characteristic (ROC) analysis. A significant decrease in the PFSa occurred between the 2-week and 1-year post-THA timepoints (7.8±4.3° vs. 4.2±3.6°, p<0.001), with no notable change in other alignment parameters. At 1-year post-THA, the CA of 12 (16%) patients had increased to 4.5±4.4°. Only the preoperative APPa was positively associated with ΔCA (β=0.165, p=0.020). The ROC analysis revealed that the optimal cut-off value for increased CA in the APPa is 2.1° (area under the curve, 0.700; p=0.020; odds ratio, 4.80). The APPa change predicted increased CA, which emphasizes the importance of the use of preoperative standing radiography for identifying the optimal cup positioning for post-THA changes in CA.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"31-37"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Nomogram that Predicts Chronic Hemodialysis Patients' Survival Based on Their Sedentary Behavior. 基于久坐行为预测慢性血液透析患者生存的一种新的Nomogram。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70068
Kentaro Sugahara, Takashi Kondo, Nobuyuki Miyatake, Hiroyuki Nishi, Kazuhiro Ujike, Kiichi Koumoto, Keiichi Namio, Shuhei Hishii, Akihiko Katayama, Hiromi Suzuki, Yorimasa Yamamoto

Appropriate treatments for chronic hemodialysis patients are a public health challenge in Japan. Sedentary behavior appears to be closely associated with these patients' survival. We thus sought to develop a nomogram that predicts survival based on the duration of chronic hemodialysis patients' sedentary behavior. One hundred twenty-four patients under chronic hemodialysis (73 men, 51 women, age 71.7±11.1 years) were enrolled in this cohort study. The patients wore a triaxial accelerometer that measured both their sedentary behavior, i.e., total sedentary behavior (minutes) and their maximum sedentary bouts (min) on non-hemodialysis days. We obtained the Kaplan-Meier curve and used the log-rank test and a Cox proportional hazards model to evaluate the relationship between the patients' sedentary behavior and their survival. We also used a Cox proportional hazards model to develop a nomogram for the patients' 5-year survival rate. Forty-six patients died during the follow-up period. When we stratified the patients by the medians of total sedentary behavior and maximum sedentary bouts, we observed significant between-group differences. After adjustment for confounding factors in a Cox proportional hazards model, total sedentary behavior and maximum sedentary bouts were identified as critical survival factors, and we generated a nomogram using an index of sedentary behavior. Our analysis results demonstrated that sedentary behavior on non-dialysis days was closely associated with the survival of the chronic hemodialysis patients, suggesting that a decrease in sedentary behavior would prolong their survival. The nomogram developed herein based on sedentary behavior may be useful for predicting the outcomes of chronic hemodialysis patients.

在日本,慢性血液透析患者的适当治疗是一项公共卫生挑战。久坐行为似乎与这些患者的生存密切相关。因此,我们试图开发一种基于慢性血液透析患者久坐行为持续时间的nomogram预测生存率。124例慢性血液透析患者(男性73例,女性51例,年龄71.7±11.1岁)纳入本队列研究。患者佩戴三轴加速度计,测量他们在非血液透析日的久坐行为,即总久坐行为(分钟)和最长久坐次数(分钟)。我们获得Kaplan-Meier曲线,并使用log-rank检验和Cox比例风险模型来评估患者久坐行为与生存之间的关系。我们还使用Cox比例风险模型来建立患者5年生存率的nomogram。46名患者在随访期间死亡。当我们根据总久坐行为和最长久坐次数的中位数对患者进行分层时,我们观察到组间存在显著差异。在Cox比例风险模型中调整混杂因素后,总久坐行为和最长久坐次数被确定为关键生存因素,我们使用久坐行为指数生成了一个nomogram。我们的分析结果表明,非透析日久坐行为与慢性血液透析患者的生存密切相关,这表明减少久坐行为可以延长患者的生存时间。本文所建立的基于久坐行为的图可能有助于预测慢性血液透析患者的预后。
{"title":"A Novel Nomogram that Predicts Chronic Hemodialysis Patients' Survival Based on Their Sedentary Behavior.","authors":"Kentaro Sugahara, Takashi Kondo, Nobuyuki Miyatake, Hiroyuki Nishi, Kazuhiro Ujike, Kiichi Koumoto, Keiichi Namio, Shuhei Hishii, Akihiko Katayama, Hiromi Suzuki, Yorimasa Yamamoto","doi":"10.18926/AMO/70068","DOIUrl":"10.18926/AMO/70068","url":null,"abstract":"<p><p>Appropriate treatments for chronic hemodialysis patients are a public health challenge in Japan. Sedentary behavior appears to be closely associated with these patients' survival. We thus sought to develop a nomogram that predicts survival based on the duration of chronic hemodialysis patients' sedentary behavior. One hundred twenty-four patients under chronic hemodialysis (73 men, 51 women, age 71.7±11.1 years) were enrolled in this cohort study. The patients wore a triaxial accelerometer that measured both their sedentary behavior, i.e., total sedentary behavior (minutes) and their maximum sedentary bouts (min) on non-hemodialysis days. We obtained the Kaplan-Meier curve and used the log-rank test and a Cox proportional hazards model to evaluate the relationship between the patients' sedentary behavior and their survival. We also used a Cox proportional hazards model to develop a nomogram for the patients' 5-year survival rate. Forty-six patients died during the follow-up period. When we stratified the patients by the medians of total sedentary behavior and maximum sedentary bouts, we observed significant between-group differences. After adjustment for confounding factors in a Cox proportional hazards model, total sedentary behavior and maximum sedentary bouts were identified as critical survival factors, and we generated a nomogram using an index of sedentary behavior. Our analysis results demonstrated that sedentary behavior on non-dialysis days was closely associated with the survival of the chronic hemodialysis patients, suggesting that a decrease in sedentary behavior would prolong their survival. The nomogram developed herein based on sedentary behavior may be useful for predicting the outcomes of chronic hemodialysis patients.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"9-16"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of D-dimer Assay to Confirm the Course of Overt Venous Thromboembolism (VTE) in Cancer Patients. d -二聚体测定在确定癌症患者明显静脉血栓栓塞(VTE)病程中的作用。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-02-01 DOI: 10.18926/AMO/70067
Hidenaru Yamaoka, Masashi Yoshida, Toshihiro Sarashina, Satoshi Akagi, Toru Miyoshi, Mitsuru Munemasa, Kazufumi Nakamura, Hiroshi Ito, Shinsuke Yuasa

Venous thromboembolism (VTE) is a serious complication in patients with cancer. In this population, the presence of thrombi is often assessed at cancer diagnosis by measuring D-dimer levels, which have high sensitivity but low specificity for identifying VTE at this clinical time point. However, the usefulness of D-dimer measurement during anticoagulation therapy has not been fully established, despite its widespread use. In this retrospective observational study, we investigated whether D-dimer measurement during anticoagulation therapy in cancer patients could predict overt VTE at follow-up. The study included patients who underwent D-dimer testing and contrast-enhanced computed tomography between 30 and 100 days after initiation of anticoagulation therapy. Eighty-two patients were included: 60 with cancer and 22 without. The diagnostic performance of D-dimer for overt VTE was as follows: sensitivity, 85.7%; specificity, 87.2%; positive predictive value, 78.3%; and negative predictive value, 89.2%. These findings suggest that D-dimer measurement at follow-up has high sensitivity and specificity for overt VTE in cancer patients and may aid in assessing thrombotic status. Clinically, if anticoagulation therapy is continued until D-dimer levels become negative, the absence of overt VTE could be inferred without additional invasive testing.

静脉血栓栓塞(VTE)是癌症患者的严重并发症。在这一人群中,血栓的存在通常通过测量d -二聚体水平来评估癌症诊断,在该临床时间点识别静脉血栓栓塞具有高灵敏度但低特异性。然而,d -二聚体测量在抗凝治疗中的有用性尚未完全确定,尽管它被广泛使用。在这项回顾性观察性研究中,我们研究了癌症患者抗凝治疗期间d -二聚体的测量是否可以预测随访时明显的静脉血栓栓塞。该研究包括在抗凝治疗开始后30至100天内进行d -二聚体检测和增强计算机断层扫描的患者。共纳入82名患者:60名癌症患者和22名非癌症患者。d -二聚体对明显静脉血栓栓塞的诊断表现如下:敏感性85.7%;特异性,87.2%;阳性预测值为78.3%;阴性预测值为89.2%。这些发现表明,d -二聚体在随访中对癌症患者的明显静脉血栓形成具有高敏感性和特异性,并可能有助于评估血栓形成状态。临床上,如果抗凝治疗持续到d -二聚体水平变为阴性,则无需额外的侵入性检测即可推断没有明显的静脉血栓栓塞。
{"title":"Usefulness of D-dimer Assay to Confirm the Course of Overt Venous Thromboembolism (VTE) in Cancer Patients.","authors":"Hidenaru Yamaoka, Masashi Yoshida, Toshihiro Sarashina, Satoshi Akagi, Toru Miyoshi, Mitsuru Munemasa, Kazufumi Nakamura, Hiroshi Ito, Shinsuke Yuasa","doi":"10.18926/AMO/70067","DOIUrl":"10.18926/AMO/70067","url":null,"abstract":"<p><p>Venous thromboembolism (VTE) is a serious complication in patients with cancer. In this population, the presence of thrombi is often assessed at cancer diagnosis by measuring D-dimer levels, which have high sensitivity but low specificity for identifying VTE at this clinical time point. However, the usefulness of D-dimer measurement during anticoagulation therapy has not been fully established, despite its widespread use. In this retrospective observational study, we investigated whether D-dimer measurement during anticoagulation therapy in cancer patients could predict overt VTE at follow-up. The study included patients who underwent D-dimer testing and contrast-enhanced computed tomography between 30 and 100 days after initiation of anticoagulation therapy. Eighty-two patients were included: 60 with cancer and 22 without. The diagnostic performance of D-dimer for overt VTE was as follows: sensitivity, 85.7%; specificity, 87.2%; positive predictive value, 78.3%; and negative predictive value, 89.2%. These findings suggest that D-dimer measurement at follow-up has high sensitivity and specificity for overt VTE in cancer patients and may aid in assessing thrombotic status. Clinically, if anticoagulation therapy is continued until D-dimer levels become negative, the absence of overt VTE could be inferred without additional invasive testing.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 1","pages":"1-7"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Thoron Inhalation and Cyclosporin A Treatment on Dextran Sulfate Sodium-Induced Oxidative Damage in Mice. 吸入刺龙和环孢素A对硫酸葡聚糖钠诱导小鼠氧化损伤的影响。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69844
Ayumi Tanaka, Shota Naoe, Reiju Takenaka, Norie Kanzaki, Akihiro Sakoda, Kiyonori Yamaoka, Takahiro Kataoka

Radon (222Rn; Rn) and thoron (220Rn; Tn) inhalation have been reported to enhance antioxidant activity in various organs. However, the effects of Tn on the colon have not been investigated. This study aimed to clarify the effects of Tn inhalation, alone and in combination with cyclosporin A (CsA), on dextran sulfate sodium (DSS)-induced colitis, and the accompanying oxidative stress, in mice. Male BALB/c mice were subjected to continuous 8-day Tn inhalation (c-Tn, 533±128 Bq/m3) or alternate-day Tn inhalation over the same period (f-Tn, 577±63Bq/m3), followed by treatment with 3% DSS and either CsA or vehicle for 7 days. Although the disease activity index (DAI) decreased significantly by day 2 in the c-Tn group, scores remained significantly higher than those in the f-Tn group. In the c-Tn group, superoxide dismutase and catalase activity in the colon were significantly elevated compared with those in sham controls. Thus, DSS-induced damage was effectively inhibited in the earlier stages by the c-Tn mode of inhalation than by the f-Tn mode. These findings suggest that continuous Tn inhalation more effectively attenuated early colitis symptoms than alternate-day inhalation, potentially through upregulation of antioxidant defenses. Tn and CsA showed no combined effects.

据报道,吸入氡(222Rn; Rn)和钍(220Rn; Tn)可增强各器官的抗氧化活性。然而,Tn对结肠的影响尚未被研究。本研究旨在阐明Tn单独吸入和与环孢素A (CsA)联合吸入对小鼠葡聚糖硫酸钠(DSS)诱导的结肠炎及其氧化应激的影响。雄性BALB/c小鼠连续吸入8天Tn (c-Tn, 533±128 Bq/m3)或同期隔天吸入Tn (f-Tn, 577±63Bq/m3),然后用3% DSS和CsA或载药治疗7天。尽管c-Tn组的疾病活动指数(DAI)在第2天显著下降,但评分仍明显高于f-Tn组。与对照组相比,c-Tn组结肠超氧化物歧化酶和过氧化氢酶活性显著升高。因此,吸入c-Tn比吸入f-Tn更能在早期有效地抑制dss引起的损伤。这些发现表明,连续吸入Tn比隔天吸入更有效地减轻早期结肠炎症状,可能是通过上调抗氧化防御。Tn和CsA无联合效应。
{"title":"Effects of Thoron Inhalation and Cyclosporin A Treatment on Dextran Sulfate Sodium-Induced Oxidative Damage in Mice.","authors":"Ayumi Tanaka, Shota Naoe, Reiju Takenaka, Norie Kanzaki, Akihiro Sakoda, Kiyonori Yamaoka, Takahiro Kataoka","doi":"10.18926/AMO/69844","DOIUrl":"https://doi.org/10.18926/AMO/69844","url":null,"abstract":"<p><p>Radon (222Rn; Rn) and thoron (220Rn; Tn) inhalation have been reported to enhance antioxidant activity in various organs. However, the effects of Tn on the colon have not been investigated. This study aimed to clarify the effects of Tn inhalation, alone and in combination with cyclosporin A (CsA), on dextran sulfate sodium (DSS)-induced colitis, and the accompanying oxidative stress, in mice. Male BALB/c mice were subjected to continuous 8-day Tn inhalation (c-Tn, 533±128 Bq/m3) or alternate-day Tn inhalation over the same period (f-Tn, 577±63Bq/m3), followed by treatment with 3% DSS and either CsA or vehicle for 7 days. Although the disease activity index (DAI) decreased significantly by day 2 in the c-Tn group, scores remained significantly higher than those in the f-Tn group. In the c-Tn group, superoxide dismutase and catalase activity in the colon were significantly elevated compared with those in sham controls. Thus, DSS-induced damage was effectively inhibited in the earlier stages by the c-Tn mode of inhalation than by the f-Tn mode. These findings suggest that continuous Tn inhalation more effectively attenuated early colitis symptoms than alternate-day inhalation, potentially through upregulation of antioxidant defenses. Tn and CsA showed no combined effects.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"421-429"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica Okayama
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1